Literature DB >> 11259503

Role of Egr-1 in cAMP-dependent protein kinase regulation of the phenylethanolamine N-methyltransferase gene.

T C Tai1, K Morita, D L Wong.   

Abstract

The molecular mechanism by which cAMP activates the rat phenylethanolamine N-methyltransferase (PNMT) gene was examined by transient transfection of the wild-type rat PNMT promoter-luciferase reporter gene construct pGL3RP893 into PC12 cells. Forskolin treatment (10 microM) of the transfected cells for 3--6 h maximally induced luciferase threefold. Induction by forskolin was mimicked by the cAMP analog, 8-Br-cAMP, and prevented in PC12 cells pretreated with the protein kinase A (PKA) inhibitor H-89 or co-transfected with an expression construct for PKI, a polypeptide inhibitor of PKA. Furthermore, forskolin did not activate the PNMT promoter when the 893 bp PNMT promoter-reporter gene construct was transfected into the PKA-deficient cell line, A126. Detailed examination of the forskolin responsiveness of PNMT constructs harboring > or = 60 bp and < 893 bp of PNMT promoter demonstrated that the cAMP-responsive element(s) lay between < 392 bp and > or =60 bp. Within this region of the promoter lies a functional binding element for Egr-1, a transcriptional activator of the PNMT gene. Forskolin treatment of PC12 cells also rapidly increased nuclear levels of Egr-1 and the catalytic subunit of PKA (PKA-C), with the rise in PKA-C preceding that of Egr-1. Mutation of the --165 bp Egr-1 site markedly decreased forskolin activation of the PNMT promoter. These findings demonstrate that the rat PNMT gene promoter can be activated via the cAMP-PKA signal transduction pathway, mediated by the immediate early gene transcription factor, Egr-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259503     DOI: 10.1046/j.1471-4159.2001.00189.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Stress and adrenergic function: HIF1α, a potential regulatory switch.

Authors:  Dona Lee Wong; T C Tai; David C Wong-Faull; Robert Claycomb; Brenda J Siddall; Rose Ann Bell; Richard Kvetnansky
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

2.  Discrete signal transduction pathway utilization by a neuropeptide (PACAP) and a cytokine (TNF-alpha) first messenger in chromaffin cells, inferred from coupled transcriptome-promoter analysis of regulated gene cohorts.

Authors:  Babru Samal; Djida Ait-Ali; Stephen Bunn; Tomris Mustafa; Lee E Eiden
Journal:  Peptides       Date:  2013-04-19       Impact factor: 3.750

3.  Regulation of rat dopamine beta-hydroxylase gene transcription by early growth response gene 1 (Egr1).

Authors:  Shu-Yuan Cheng; Lidia I Serova; Dina Glazkova; Esther L Sabban
Journal:  Brain Res       Date:  2007-12-05       Impact factor: 3.252

Review 4.  PACAP signaling in stress: insights from the chromaffin cell.

Authors:  Lee E Eiden; Andrew C Emery; Limei Zhang; Corey B Smith
Journal:  Pflugers Arch       Date:  2017-09-30       Impact factor: 3.657

5.  Role of reactive oxygen species in the neural and hormonal regulation of the PNMT gene in PC12 cells.

Authors:  James A G Crispo; Dominique R Ansell; Gino Ubriaco; T C Tai
Journal:  Oxid Med Cell Longev       Date:  2011-10-09       Impact factor: 6.543

6.  Fetal programming of adrenal PNMT and hypertension by glucocorticoids in WKY rats is dose and sex-dependent.

Authors:  Sandhya Khurana; Julie Grandbois; Sujeenthar Tharmalingam; Alyssa Murray; Kelly Graff; Phong Nguyen; T C Tai
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

7.  A systems approach identifies co-signaling molecules of early growth response 1 transcription factor in immobilization stress.

Authors:  Nikolaos A Papanikolaou; Andrej Tillinger; Xiaoping Liu; Athanasios G Papavassiliou; Esther L Sabban
Journal:  BMC Syst Biol       Date:  2014-09-11

Review 8.  Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis.

Authors:  Collin J Byrne; Sandhya Khurana; Aseem Kumar; T C Tai
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-28       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.